BDSX

Biodesix Inc.

Price

$27.56

return (12m)

208.69%

p/e

-9.15

p/bv

27.78

DIVIDEND YIELD

0.00%

BDSX price

Biodesix

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment BDSX

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

28.25%

3 months

68.87%

1 year

208.69%

2 years

-25.51%

5 years

-84.27%

10 years

0.00%

Asset Comparator

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Fundamentals BDSX

Valuation

P/E

-9.15

Sector -0.16

Industry 2.77

P/BV

27.78

Sector 1.93

Industry 2.37

P/Revenue (PSR)

2.47

Sector 1.67

Industry 1.97

EV/EBITDA

Sector -55.30

Industry -73.25

EV/EBIT

Sector -488.87

Industry -73.47

P/EBITDA

Sector -178.48

Industry -262.99

P/EBIT

Sector -214.62

Industry -268.43

P/Total Assets

2.66

Sector 0.91

Industry 1.07

P/Net Current Assets

-5.96

Sector -24.70

Industry -5.25

P/Working Capital

8.98

Sector -5.32

Industry 3.11

EPS

-2.78

Sector -0.79

Industry -0.61

BVPS

0.91

Sector 3.79

Industry 4.57

Efficiency

Gross Margin

82.51%

Sector 48.28%

Industry 50.49%

EBITDA Margin

0.00%

Sector -5,407,515.68%

Industry -10.73%

EBIT Margin

0.00%

Sector -62.93%

Industry -21.31%

Operating Margin

-20.02%

Sector -23.12%

Industry -27.36%

Net Profit Margins

-26.97%

Sector -27.40%

Industry -30.91%

Asset Turnover

0.28

Sector 0.13

Industry 0.15

Profitability

ROE

-303.72%

Sector -31.93%

Industry -27.86%

ROA

-29.12%

Sector -28.25%

Industry -27.56%

ROIC

0.00%

Sector -317.33%

Industry -57.09%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

Sector -

Industry -

Debt

Current Ratio

2.85

Sector 1.85

Industry 1.98

Net Debt / EBITDA

Sector -42.46

Industry -72.45

Net Debt / EBIT

Sector -37.26

Industry -7.11

Net Debt / Equity

5.12

Sector -1.04

Industry -0.12

Gross Debt / Equity

5.12

Sector -0.72

Industry 0.10

Equity/Assets

0.10

Sector 0.43

Industry 0.45

Liabilities/Assets

0.90

Sector 0.48

Industry 0.51

Growth

5Y Revenue CAGR

13.56%

Sector -

Industry -

5Y Earnings CAGR

-8.44%

Sector -

Industry -

Fundamentals BDSX

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
BDSX Biodesix Inc.	$27.56	193.19%	0.00%	-9.15	27.78	-303.72%	-26.97%
HCA HCA Healthcare Inc.	$419.06	4.14%	0.70%	12.08	-29.56	-244.72%	10.07%
FMS Fresenius Medical Care AG & Co.	$23.03	-5.86%	2.60%	11.56	0.81	7.01%	4.84%
HUM Humana Inc.	$390.51	33.27%	0.92%	35.82	2.41	6.72%	0.89%
DVA DaVita Inc.	$181.71	32.09%	0.00%	9.64	-23.80	-246.80%	8.49%
LH Laboratory Corporation of America Holdings	$336.01	21.85%	0.85%	27.67	3.22	11.64%	6.99%
ALHC Alignment Healthcare Inc.	$13.77	-14.71%	0.00%	68.30	10.49	15.35%	0.89%
SGRY Surgery Partners Inc.	$13.93	-38.61%	0.00%	21.97	0.58	2.64%	2.43%
APR Apria Inc.	$0.00	-	0.00%	22.62	36.06	159.41%	5.53%
LLY Eli Lilly and Compay	$1,169.97	61.21%	0.52%	41.58	-	-%	33.53%
ISRG Intuitive Surgical Inc.	$371.80	-21.09%	0.00%	41.88	7.23	17.26%	28.62%
SNY Sanofi	$44.84	-7.34%	3.87%	7.43	1.37	18.43%	13.81%
NVS Novartis AG	$153.04	22.95%	1.96%	28.21	7.75	27.47%	26.57%
TMO Thermo Fisher Scientific Inc.	$618.91	27.34%	0.29%	33.36	4.42	13.26%	15.08%
ABT Abbott Laboratories	$112.42	-12.47%	2.33%	33.60	3.57	10.61%	11.65%
MDT Medtronic PLC	$91.17	3.05%	3.09%	24.60	2.36	9.59%	13.20%
GSK GlaxoSmithKline PLC	$50.24	31.67%	3.42%	15.92	4.50	28.24%	14.54%
BSX Boston Scientific Corp.	$46.77	-55.83%	0.00%	17.71	0.00	-%	19.57%
TMDX TransMedics Group Inc.	$91.75	-20.34%	0.00%	21.60	6.32	29.28%	22.69%
IDXX IDEXX Laboratories Inc.	$553.20	-13.68%	0.00%	38.78	27.41	70.67%	25.03%
RMD ResMed Inc.	$238.60	-14.30%	1.04%	22.12	5.18	23.41%	27.44%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

BDSX Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Biodesix

Biodesix Inc.

Average Investor10 user rating

4.0 (3 people)

United States

21 years

Founded: 2005

2020

Time since IPO - 6 years

200

Employees

Biodesix Inc. (United States) is listed on the Nasdaq and has a market capitalization of $253.90 million, with shareholders equity totaling $9.14 million.

The company employs approximately 200 people and operates in the Health sector, within the Health Services and Providers industry.

Over the past 12 months, Biodesix Inc. reported $102.93 million in revenue, generating net income of $-27.76 million.

Key financial metrics include a P/E ratio of -9.15, a price-to-book (P/B) ratio of 27.78, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker BDSX.

Market cap

$253.90 million

Net worth

$9.14 million

$9,140,000.00

Assets

$95.33 million

$95,330,000.00

Total Shares Outstanding

10.00 million

10,000,000

Average Daily Trading Volume

$101.68 Thousand

$101,679.92

Sector

Health

Industry

Health Services and Providers

BDSX

BDSX revenue and profits

Financial Results BDSX

DRAG THE FRAME TO SEE MORE DATA

BDSX cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

CVS - CVS Health

$93.51 31,87% (12M)

P/E

-0.84

2.83%

ROE

-178.93%

P/BV

1.51

CI - Cigna

$279.22 --4,61% (12M)

P/E

10.77

2.20%

ROE

16.04%

P/BV

1.73

CNC - Centene

$64.37 121,66% (12M)

P/E

-6.35

0.00%

ROE

-22.56%

P/BV

1.43

HUM - Humana

$390.51 30,46% (12M)

P/E

35.82

0.92%

ROE

6.72%

P/BV

2.41

SNY - Sanofi

$44.84 --5,80% (12M)

P/E

7.43

3.87%

ROE

18.43%

P/BV

1.37

LLY - Eli Lilly

$1,169.97 60,50% (12M)

P/E

41.58

0.52%

ROE

P/BV

HCA - HCA Healthcare

$419.06 4,42% (12M)

P/E

12.08

0.70%

ROE

-244.72%

P/BV

-29.56

NVS - Novartis

$153.04 23,28% (12M)

P/E

28.21

1.96%

ROE

27.47%

P/BV

7.75

CVS - CVS Health

$93.51 31,87% (12 M)

P/L

-0.84

2.83%

ROE

-178.93%

P/VP

1.51

CI - Cigna

$279.22 --4,61% (12 M)

P/L

10.77

2.20%

ROE

16.04%

P/VP

1.73

CNC - Centene

$64.37 121,66% (12 M)

P/L

-6.35

0.00%

ROE

-22.56%

P/VP

1.43

HUM - Humana

$390.51 30,46% (12 M)

P/L

35.82

0.92%

ROE

6.72%

P/VP

2.41

SNY - Sanofi

$44.84 --5,80% (12 M)

P/L

7.43

3.87%

ROE

18.43%

P/VP

1.37

LLY - Eli Lilly

$1,169.97 60,50% (12 M)

P/L

41.58

0.52%

ROE

P/VP

HCA - HCA Healthcare

$419.06 4,42% (12 M)

P/L

12.08

0.70%

ROE

-244.72%

P/VP

-29.56

NVS - Novartis

$153.04 23,28% (12 M)

P/L

28.21

1.96%

ROE

27.47%

P/VP

7.75

Frequently Asked Questions

What is the price of Biodesix (BDSX) today?

A cotação de Biodesix (BDSX) hoje está em US$ 27.56, com uma variação de 208.69% em relação ao último ano. A cotação de Biodesix (BDSX) iniciou o ano negociando na casa dos US$ 6.80 e hoje está em US$ 27.56. Acompanhe o gráfico de cotação em tempo real, a cotação histórica de Biodesix (BDSX) e dados de ações do Ibovespa e mercados internacionais.

Quando Biodesix (BDSX) paga dividendos?

Biodesix (BDSX) não distribuiu dividendos no último ano.

Is Biodesix (BDSX) a good investment?

Atualmente, Biodesix (BDSX) está cotada a US$ 27.56, com um P/L de -9.15, representando um desvio de -4,313% em relação ao seu P/L médio histórico. No último ano, a ação apresentou uma variação de 208.69 em sua cotação e distribuiu US$ 0.00 em dividendos, resultando em um Dividend Yield de 0.00%. O retorno total do acionista foi de 208.69%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy Biodesix (BDSX) stock?

Investir em ações de Biodesix (BDSX) pode ser feito de duas formas: comprando a stock uma empresa estrangeira e é atrelado ao dólar.

How much would 100 shares of Biodesix (BDSX) yield today?

A rentabilidade de Biodesix (BDSX) foi de 28.25% no último mês, 208.69% no último ano e -84.27% nos últimos 5 anos (já considerando valorização e dividendos).

Nos últimos 12 meses, a empresa pagou um total de US$ 0.00 em dividendos, um Dividend Yield de 0.00%.

Se você quisesse comprar 100 ações de Biodesix (BDSX) hoje, o investimento total seria de US$ 2,756.00, com base na cotação atual de US$ 27.56.

Based on historical performance, the investment would have grown to approximately:

Em 1 ano: US$ 8,507.50
Em 5 anos: US$ 433.52
Em 10 anos: US$ 2,756.00

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

BDSX

Biodesix Inc.

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment BDSX

Valuation

Efficiency

Profitability

Dividends

Debt

Growth

COMPARING BDSX WITH OTHER STOCK

current DY: 0.00%

5-year average DY: 0.00%

ABOUT Biodesix

Biodesix Inc.

United States

21 years

2020

200

PROFIT X PRICE BDSX

Financial Results BDSX

BDSX cash flow

Asset, Revenue and Profit Growth - BDSX

BDSX balance sheet

CVS - CVS Health

CI - Cigna

CNC - Centene

HUM - Humana

SNY - Sanofi

LLY - Eli Lilly

HCA - HCA Healthcare

NVS - Novartis

CVS - CVS Health

CI - Cigna

CNC - Centene

HUM - Humana

SNY - Sanofi

LLY - Eli Lilly

HCA - HCA Healthcare

NVS - Novartis

Frequently Asked Questions